NCT00025129View on ClinicalTrials.gov

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Study Completion Date

May 31, 2004

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

laromustine

Trial Locations (3)

85712

Arizona Clinical Research Center, Tucson

06520-8028

Yale Comprehensive Cancer Center, New Haven

06516

Veterans Affairs Medical Center - West Haven, West Haven

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00025129 - VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | Biotech Hunter | Biotech Hunter